View in EDS HTML Full Text PDF Full Text

Safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy: A 36‐week analysis from FOREST‐HCM.

Saved in:
Bibliographic Details
Title: Safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy: A 36‐week analysis from FOREST‐HCM.
Authors: Masri, Ahmad1 (AUTHOR) masria@ohsu.edu, Barriales‐Villa, Roberto2 (AUTHOR), Elliott, Perry3 (AUTHOR), Nassif, Michael E.4 (AUTHOR), Oreziak, Artur5 (AUTHOR), Owens, Anjali T.6 (AUTHOR), Tower‐Rader, Albree7 (AUTHOR), Heitner, Stephen B.8 (AUTHOR), Kupfer, Stuart8 (AUTHOR), Malik, Fady I.8 (AUTHOR), Melloni, Chiara8 (AUTHOR), Meng, Lisa8 (AUTHOR), Wei, Jenny8 (AUTHOR), Saberi, Sara9 (AUTHOR)
Source: European Journal of Heart Failure. Sep2024, Vol. 26 Issue 9, p1993-1998. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13889842
DOI:10.1002/ejhf.3372